LTNC Forms New Subsidiary Elevate Health & Wellness Nutritionals
Labor Smart, Inc. (OTC PINK:LTNC) has launched a new subsidiary, Elevate Health and Wellness Nutritionals, in partnership with Elevate Health and Wellness This new venture will focus on direct-to-consumer distribution of vitamins and supplements, initially targeting patients using GLP-1 weight loss medications like Semaglutide and Terzepatide.
Joseph Curshen, CEO of Elevate, will lead this division, bringing his experience in scaling direct-to-consumer wellness brands. His track record includes acquiring over 30,000 new patients and building a 13,000+ patient brand in just nine months. The new product line, set to launch this fall, aims to support individuals on medical weight loss programs by offsetting side effects and improving results.
This marks LTNC's fourth wholly owned subsidiary, joining Next Gen Beverages, Illumination Holdings, and Next Gen Holdings, contributing to the company's diversified portfolio.
Labor Smart, Inc. (OTC PINK:LTNC) ha lanciato una nuova filiale, Elevate Health and Wellness Nutritionals, in collaborazione con Elevate Health and Wellness. Questa nuova iniziativa si concentrerà sulla distribuzione diretta al consumatore di vitamine e integratori, mirata inizialmente ai pazienti che utilizzano farmaci per la perdita di peso GLP-1 come Semaglutide e Terzepatide.
Joseph Curshen, CEO di Elevate, guiderà questa divisione, portando la sua esperienza nel far crescere marchi di wellness diretti al consumatore. Il suo curriculum comprende l'acquisizione di oltre 30.000 nuovi pazienti e la costruzione di un marchio con più di 13.000 pazienti in soli nove mesi. La nuova linea di prodotti, prevista per il lancio questo autunno, mira a supportare le persone che seguono programmi di perdita di peso medica, alleviando gli effetti collaterali e migliorando i risultati.
Questo segna la quarta filiale interamente controllata da LTNC, unendosi a Next Gen Beverages, Illumination Holdings e Next Gen Holdings, contribuendo al portafoglio diversificato dell'azienda.
Labor Smart, Inc. (OTC PINK:LTNC) ha lanzado una nueva subsidiaria, Elevate Health and Wellness Nutritionals, en colaboración con Elevate Health and Wellness. Esta nueva iniciativa se centrará en la distribución directa al consumidor de vitaminas y suplementos, dirigiéndose inicialmente a pacientes que utilizan medicamentos para la pérdida de peso GLP-1 como Semaglutida y Terzepatida.
Joseph Curshen, CEO de Elevate, liderará esta división, aportando su experiencia en la expansión de marcas de bienestar directas al consumidor. Su trayectoria incluye la adquisición de más de 30,000 nuevos pacientes y la creación de una marca con más de 13,000 pacientes en solo nueve meses. La nueva línea de productos, que se lanzará este otoño, tiene como objetivo apoyar a las personas en programas médicos de pérdida de peso al mitigar los efectos secundarios y mejorar los resultados.
Esto marca la cuarta subsidiaria de propiedad total de LTNC, uniéndose a Next Gen Beverages, Illumination Holdings y Next Gen Holdings, contribuyendo al portafolio diversificado de la empresa.
Labor Smart, Inc. (OTC PINK:LTNC)은 Elevate Health and Wellness와 협력하여 새로운 자회사 Elevate Health and Wellness Nutritionals를 출범했습니다. 이 새로운 사업은 Semaglutide와 Terzepatide와 같은 GLP-1 체중 감량 약물을 사용하는 환자들을 초기 대상으로 하여 비타민과 보충제를 직접 소비자에게 배급하는 데 중점을 둘 것입니다.
Elevate의 CEO인 Joseph Curshen이 이 부서를 이끌며, 그는 직접 소비자에게 판매되는 웰니스 브랜드를 확장하는 경험을 가지고 있습니다. 그의 경력에는 30,000명 이상의 신규 환자를 획득하고 단 9개월 만에 13,000명 이상의 환자를 보유한 브랜드를 구축한 것이 포함되어 있습니다. 이번 가을 출시될 새로운 제품 라인은 의학적 체중 감량 프로그램에 참여하는 개인들을 지원하기 위해 부작용을 완화하고 결과를 개선하는 것을 목표로 하고 있습니다.
이는 LTNC의 네 번째 전액 출자 자회사가 되며, Next Gen Beverages, Illumination Holdings 및 Next Gen Holdings에 합류하여 회사의 다변화된 포트폴리오에 기여하고 있습니다.
Labor Smart, Inc. (OTC PINK:LTNC) a lancé une nouvelle filiale, Elevate Health and Wellness Nutritionals, en partenariat avec Elevate Health and Wellness. Cette nouvelle initiative se concentrera sur la distribution directe aux consommateurs de vitamines et de suppléments, en ciblant initialement les patients utilisant des médicaments de perte de poids GLP-1 tels que la sémaglutide et le térzapatide.
Joseph Curshen, PDG d'Elevate, dirigera cette division, mettant à profit son expérience dans le développement de marques de bien-être directement destinées aux consommateurs. Son parcours inclut l'acquisition de plus de 30 000 nouveaux patients et la constitution d'une marque de plus de 13 000 patients en seulement neuf mois. La nouvelle gamme de produits, prévue pour cet automne, vise à soutenir les personnes suivant des programmes de perte de poids médicales en atténuant les effets secondaires et en améliorant les résultats.
Cela marque la quatrième filial à propriété exclusive de LTNC, rejoignant Next Gen Beverages, Illumination Holdings et Next Gen Holdings, contribuant ainsi au portefeuille diversifié de l'entreprise.
Labor Smart, Inc. (OTC PINK:LTNC) hat eine neue Tochtergesellschaft, Elevate Health and Wellness Nutritionals, in Partnerschaft mit Elevate Health and Wellness gegründet. Dieses neue Unternehmen wird sich auf den Direktvertrieb von Vitaminen und Nahrungsergänzungsmitteln konzentrieren und zunächst Patienten ansprechen, die GLP-1-Abnehmmittel wie Semaglutid und Terzepatid verwenden.
Joseph Curshen, CEO von Elevate, wird diese Abteilung leiten und bringt seine Erfahrung im Wachstum von Direktvertriebs-Wellnessmarken ein. Zu seinen Erfolgen gehört die Akquise von über 30.000 neuen Patienten und der Aufbau einer Marke mit mehr als 13.000 Patienten in nur neun Monaten. Die neue Produktlinie, die diesen Herbst auf den Markt kommen soll, zielt darauf ab, Menschen in medizinischen Abnehmprogrammen zu unterstützen, indem Nebenwirkungen gemildert und Ergebnisse verbessert werden.
Dies ist die vierte hundertprozentige Tochtergesellschaft von LTNC, die sich Next Gen Beverages, Illumination Holdings und Next Gen Holdings anschließt und zur diversifizierten Portfolio des Unternehmens beiträgt.
- Launch of new subsidiary Elevate Health and Wellness Nutritionals
- Partnership with established online medical weight loss company
- Experienced leadership with Joseph Curshen as CEO of Elevate division
- Targeting growing market of GLP-1 weight loss medication users
- Addition of new revenue stream to LTNC's portfolio
- None.
JACKSON, WY / ACCESSWIRE / September 13, 2024 / Labor Smart, Inc. (OTC PINK:LTNC) proudly announces its launch of a new subsidiary Elevate Health and Wellness Nutritionals in partnership with Elevate Health and Wellness LLC, an established online medical weight loss company which offers patients GLP-1 weight loss medications Semaglutide and Terzepatide.
Joseph Curshen, CEO of Elevate, brings a wealth of experience in scaling and managing successful direct-to-consumer ventures to his new role with Labor Smart, Inc. (LTNC). As the head of the Elevate division, Joseph will lead the direct-to-consumer distribution of a new vitamin and supplement line. The product line will initially focus on helping patients who are prescribed GLP-1 medications.
Joseph's track record in the telemedicine industry is distinguished by significant achievements, including the acquisition of over 30,000 new patients across multiple direct-to-consumer wellness brands. Notably, he has played a pivotal role in scaling three successful online direct-to-consumer wellness brands, including building a 13,000+ patient brand within just nine months. Under his leadership, his current direct-to-consumer wellness business has grown into a multimillion-dollar operation entirely through organic growth without outside capital.
This new brand of supplements will help support those individuals using medical weight loss programs to offset side effects while improving results. Elevate Health President Joseph commented "We've established a strong customer base of clients that are having success with the GLP-1 medications, albeit with some of the side effects. Being able to offer additional products to help offset these conditions will help improve results create a more pleasurable client experience. These new products will launch this fall.
LTNC Co-CEO Tom Zarro said "We're excited about this opportunity as it brings another revenue stream under our portfolio of subsidiaries that mutually support each other. This acquisition makes our 4th wholly owned subsidiary for Labor Smart. Currently we have Next Gen Beverages, Illumination Holdings, Next Gen Holdings and now Elevate. All entities roll up to our parent and provides the financial security and benefits of a well-diversified family of companies"
About Elevate Health & Wellness LLC
Elevate Health and Wellness LLC offers individuals in the USA advanced weight management solutions, including doctor-led therapeutic interventions and medications like Semaglutide and Tirzepatide, known to enhance weight loss by targeting metabolic setpoints. Additionally, users benefit from ongoing support and direct access to medical professionals aimed at improving overall well-being.
About Labor Smart
Labor Smart, Inc. is a leading company in brand development, manufacturing, and distribution. Labor Smart, Inc. is traded on the OTC markets under ticker symbol LTNC. Its main subsidiaries include Illumination Holdings and Next Gen Beverages.
Email Communications
We encourage shareholders to register their email addresses with LOCK'DIN Beverages to stay up to date with product news and receive exclusive shareholder-only promotions. Sign up at https://lockdin.com/pages/shareholder-opt-in.
Safe Harbor Statement
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including our financial performance and projections, revenue and earnings growth, and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; and (iii) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with OTC Markets. These and other factors may cause our actual results to differ materially from any forward-looking statement. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
Contact
Investor Relations: ir@laborsmartinc.com
@LaborSmartNews
SOURCE: Labor Smart, Inc.
View the original press release on accesswire.com
FAQ
What is LTNC's new subsidiary called and what will it focus on?
Who is leading LTNC's new Elevate Health and Wellness Nutritionals division?
When will LTNC's new supplement product line be launched?
How many wholly owned subsidiaries does LTNC now have?
